EIT – Strategic Agenda Antagna on 28/03/2012Dokumentreferens: INT/618-EESC-2012-807Referral: COM(2011) 822 - 2011/0387 (COD) Rapporteur: Mr Jacques Lemercier (Workers - GR II / France) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: EIT – Strategic Agendabg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Online dispute resolution for consumer disputes Antagna on 28/03/2012Dokumentreferens: INT/610-EESC-2012-804Referral: COM(2011) 794 final - 2011/0374 (COD) Rapporteur: Mr Jorge Pegado Liz (Diversity Europe - GR III / Portugal) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Online dispute resolution for consumer disputesbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Consumer programme 2014-2020 Antagna on 28/03/2012Dokumentreferens: INT/608-EESC-2012-802Referral: COM(2011) 707 final - 2011/0340 (COD) Rapporteur: Ms Reine-Claude Mader (Diversity Europe - GR III / France) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Consumer programme 2014-2020bg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Pharmacovigilance Regulation Antagna on 28/03/2012Dokumentreferens: INT/639-EESC-2012-812Referral: COM(2012) 51 final - 2012/0023 (COD) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Pharmacovigilance Regulationbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Pharmacovigilance Directive Antagna on 28/03/2012Dokumentreferens: INT/638-EESC-2012-811Referral: COM(2012) 52 final - 2012/0025 (COD) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Pharmacovigilance Directivebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public /medicinal products for human use Antagna on 28/03/2012Dokumentreferens: INT/637-EESC-2012-810Referral: COM(2012) 49 final - 2008/0255 (COD) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Information to the general public /medicinal products for human usebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Information to the general public / Medicinal products subject to medical prescription Antagna on 28/03/2012Dokumentreferens: INT/636-EESC-2012-809Referral: COM(2012) 48 final - 2008/0256 (COD) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Information to the general public / Medicinal products subject to medical prescriptionbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Goods package Antagna on 28/03/2012Dokumentreferens: INT/611-EESC-2012-805Referral: COM(2011) 764 - 2011/0358 (COD) - COM(2011) 773 final - 2011/0357 (COD) Rapporteur: Mr Bernardo Hernández Bataller (Diversity Europe - GR III / Spain) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Goods packagebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Horizon 2020 Antagna on 28/03/2012Dokumentreferens: INT/616-EESC-2012-00806-00-00-ac-traReferral: COM(2011) 810 final - 2011/0399 (COD) Rapporteur: Mr Gerd Wolf (Diversity Europe - GR III / Germany) Plenarsession: 479 - Mar 28, 2012 Mar 29, 2012 EESK:s yttrande: Horizon 2020bg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
People-oriented, grassroots approach / internal market Antagna on 22/02/2012Dokumentreferens: INT/563-EESC-2012-466 Rapporteur: Mr Pegado Liz (Diversity Europe - GR III / Portugal) Plenarsession: 478 - Feb 22, 2012 Feb 23, 2012 EESK:s yttrande: People-oriented, grassroots approach / internal marketbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv Downloads: Follow-up - Action taken by the EC (in FR)fr Suivi de la Commission européennefr